The U.S. Food and Drug Administration (FDA) has announced key developments in healthcare, marking advancements in drug treatment, medical device safety, and hygiene technology. Firstly, the FDA approved Fabhalta (iptacopan) for treating complement 3 glomerulopathy (C3G), a rare kidney disorder.
Imagine a world where every healthcare provider, from a general practitioner to an emergency room doctor, has immediate access to a patient's comprehensive medical history. This could be the reality for New Zealand as it embarks on the ambitious Shared Digital Health Records (SDHR) project,
The article explores the dynamic integration of electronic health record (EHR) systems within U.S. federal institutions, notably the Veterans Administration (VA) and the Department of Defense (DOD). This article sheds light on the contrasting experiences of these two agencies in implementing EHR
Hospice providers are navigating an increasingly complex regulatory landscape as they head into the current year. With heightened scrutiny on fraudulent practices and evolving telehealth policies, these professionals are poised to face significant operational hurdles. The regulations aimed at
The healthcare industry faces an escalating threat as hackers target electronic health records (EHRs) to steal Drug Enforcement Administration (DEA) registration numbers of physicians. This unauthorized access facilitates the creation and distribution of numerous fraudulent prescriptions, posing
Recent legislative actions have temporarily extended Medicare telehealth flexibilities, averting an imminent shutdown of these vital services. However, the short duration of the extension highlights a pressing need for a more permanent solution. Stopgap Legislation and Its Implications A Brief
